FERROUS FUMARATE

Post-LOE

norethindrone acetate and ethinyl estradiol and ferrous fumarate

Ichnos Glenmark Innovation

ANDAORALTABLET

Approved

Dec 2014

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

FERROUS FUMARATE (norethindrone acetate and ethinyl estradiol and ferrous fumarate) by Ichnos Glenmark Innovation is ovulation. Approved for pregnancy in women. First approved in 2014.

Drug data last refreshed 20h ago

Mechanism of Action

ovulation.

Indications (1)

pregnancy in women

Clinical Trials (1)

NCT01762995Phase 1Completed

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Started Dec 2012

24 enrolled

Infection, Human Immunodeficiency Virus

Company

Worked on FERROUS FUMARATE at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.